药明康德
(603259)
| 流通市值：3512.31亿 | | | 总市值：4309.87亿 |
| 流通股本：24.73亿 | | | 总股本：30.35亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 37,133,982,853.21 | 35,725,835,451.91 | 35,905,237,313.79 | 35,131,309,638.47 |
| 交易性金融资产 | 16,343,233,903.69 | 10,914,288,678.69 | 7,479,221,505.81 | 5,806,211,811.42 |
| 衍生金融资产 | 158,136,076.36 | 268,943,020.12 | 116,808,345.33 | 68,657,103.15 |
| 应收票据及应收账款 | 9,826,665,972.63 | 10,481,169,470.66 | 7,707,674,171.14 | 7,281,326,326.92 |
| 其中：应收票据 | 8,804,062.04 | 9,453,981.19 | 6,737,203.77 | 18,672,249.95 |
| 应收账款 | 9,817,861,910.59 | 10,471,715,489.47 | 7,700,936,967.37 | 7,262,654,076.97 |
| 预付款项 | 498,941,439.73 | 341,284,411.14 | 317,915,447.87 | 246,628,413.97 |
| 其他应收款合计 | 188,854,085.45 | 276,693,535.74 | 346,414,417.16 | 724,565,155.08 |
| 其中:应收利息 | 133,651,395.04 | 129,562,435.7 | 101,013,056.9 | 28,476,379.02 |
| 存货 | 12,593,378,256.1 | 11,126,545,964.4 | 9,965,880,371.58 | 8,993,244,894.24 |
| 合同资产 | 644,479,142.86 | 554,486,874.01 | 528,212,738.24 | 469,517,512.56 |
| 一年内到期的非流动资产 | 2,462,769,167.98 | 1,735,032,493.84 | 1,399,386,889.12 | 1,402,987,153.42 |
| 其他流动资产 | 1,938,024,948.71 | 1,722,925,904.06 | 1,402,557,817.74 | 1,526,562,259.73 |
| 流动资产合计 | 81,788,465,846.72 | 73,147,205,804.57 | 65,169,309,017.78 | 61,677,055,890.49 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,841,259,474.45 | 2,267,249,039.18 | 2,275,267,437.71 | 2,144,876,912.07 |
| 其他非流动金融资产 | 7,619,997,812.4 | 8,413,343,972.46 | 8,464,145,695 | 8,131,208,431.7 |
| 固定资产 | 18,927,930,698.16 | 19,186,567,783.42 | 19,517,849,361.35 | 19,999,931,768.14 |
| 在建工程 | 9,532,794,486.59 | 8,246,534,658.02 | 6,709,257,892.76 | 5,875,518,226.97 |
| 生产性生物资产 | 1,119,788,000 | 1,085,587,000 | 1,024,158,000 | 1,013,273,000 |
| 使用权资产 | 688,312,076.71 | 693,200,914.58 | 729,801,197.15 | 763,114,562.83 |
| 无形资产 | 1,462,717,366.38 | 1,234,897,482.06 | 1,254,435,323.44 | 1,280,523,344.96 |
| 商誉 | 862,146,942.15 | 862,656,282.89 | 863,384,053.29 | 864,388,850.17 |
| 长期待摊费用 | 300,101,007.99 | 319,940,363.19 | 337,909,304.42 | 366,834,780.31 |
| 递延所得税资产 | 872,293,294.72 | 619,506,721.78 | 565,719,437.59 | 531,296,901.24 |
| 其他非流动资产 | 139,730,173.53 | 185,861,477.13 | 503,244,620.76 | 472,945,910.23 |
| 非流动资产合计 | 43,367,071,333.08 | 43,115,345,694.71 | 42,245,172,323.47 | 41,443,912,688.62 |
| 资产总计 | 125,155,537,179.8 | 116,262,551,499.28 | 107,414,481,341.25 | 103,120,968,579.11 |
| 流动负债: | | | | |
| 短期借款 | 6,184,430,145.22 | 6,181,760,656.64 | 5,977,731,732.75 | 5,986,138,418.73 |
| 衍生金融负债 | 5,888,225.4 | 14,164,646.44 | 90,740,849.75 | - |
| 应付票据及应付账款 | 3,340,759,644.8 | 3,411,059,028.21 | 2,851,372,623.18 | 2,449,523,876.15 |
| 其中：应付票据 | - | 16,478,000 | 13,482,000 | - |
| 应付账款 | 3,340,759,644.8 | 3,394,581,028.21 | 2,837,890,623.18 | 2,449,523,876.15 |
| 合同负债 | 4,138,493,568.52 | 3,754,424,360.47 | 2,764,250,761.82 | 2,709,159,889.23 |
| 应付职工薪酬 | 2,395,759,351.72 | 1,788,003,164.92 | 1,267,117,491.99 | 2,326,308,898.74 |
| 应交税费 | 3,758,619,096.62 | 3,128,031,792.86 | 2,764,818,288.65 | 2,762,813,534.62 |
| 其他应付款合计 | 3,880,555,392.04 | 3,776,268,665.14 | 3,161,353,124.05 | 2,841,705,486.56 |
| 其中:应付利息 | 907,870.83 | 908,025 | 924,219.45 | 1,016,663.76 |
| 应付股利 | 40,295,390 | 54,606,190 | 23,606,550 | 23,606,550 |
| 一年内到期的非流动负债 | 148,075,456.08 | 155,073,709.74 | 164,100,660.51 | 159,618,101.21 |
| 其他流动负债 | - | 6,585,807,315.53 | - | - |
| 流动负债合计 | 23,852,580,880.4 | 28,794,593,339.95 | 19,041,485,532.7 | 19,235,268,205.24 |
| 非流动负债: | | | | |
| 长期借款 | 1,798,500,000 | 1,798,800,000 | 1,818,800,000 | 1,819,100,000 |
| 租赁负债 | 394,175,505.03 | 390,982,215.29 | 418,299,246.95 | 455,256,654.87 |
| 递延收益 | 908,380,684.28 | 925,830,266.67 | 919,451,614.16 | 948,171,287.5 |
| 递延所得税负债 | 747,901,888.76 | 468,350,397.91 | 444,815,538.54 | 415,458,829.98 |
| 非流动负债合计 | 3,848,958,078.07 | 3,583,962,879.87 | 3,601,366,399.65 | 3,637,986,772.35 |
| 负债合计 | 27,701,538,958.47 | 32,378,556,219.82 | 22,642,851,932.35 | 22,873,254,977.59 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 3,034,904,066 | 2,983,757,155 | 2,983,757,155 | 2,983,757,155 |
| 资本公积 | 41,026,805,667.11 | 33,960,520,398.95 | 33,200,448,846.31 | 33,077,292,637.94 |
| 减:库存股 | 6,958,220,947.94 | 6,959,789,207.14 | 3,838,766,784.75 | 3,842,179,016.17 |
| 其他综合收益 | -1,078,419,501.33 | -659,312,814.83 | -415,727,814.09 | -147,106,673.86 |
| 盈余公积 | 1,491,878,577.5 | 1,491,878,577.5 | 1,491,878,577.5 | 1,491,878,577.5 |
| 未分配利润 | 59,328,301,118.47 | 52,516,663,065.27 | 50,800,165,553.79 | 46,148,647,566.03 |
| 归属于母公司股东权益合计 | 96,845,248,979.81 | 83,333,717,174.75 | 84,221,755,533.76 | 79,712,290,246.44 |
| 少数股东权益 | 608,749,241.52 | 550,278,104.71 | 549,873,875.14 | 535,423,355.08 |
| 股东权益合计 | 97,453,998,221.33 | 83,883,995,279.46 | 84,771,629,408.9 | 80,247,713,601.52 |
| 负债和股东权益合计 | 125,155,537,179.8 | 116,262,551,499.28 | 107,414,481,341.25 | 103,120,968,579.11 |
| 公告日期 | 2026-10-27 | 2026-08-04 | 2026-04-28 | 2026-03-24 |
| 审计意见(境内) | | | | 标准无保留意见 |